Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019;49(4):263-270.
doi: 10.1159/000497445. Epub 2019 Feb 28.

Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study

Anna Jovanovich  1   2 , Zhiying You  3 , Tamara Isakova  4 , Kristen Nowak  3 , Alfred Cheung  5   6 , Myles Wolf  7 , Michel Chonchol  3 , Jessica Kendrick  3
Affiliations
Randomized Controlled Trial

Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study

Anna Jovanovich et al. Am J Nephrol. 2019.

Abstract

Background: Long-term patterns of fibroblast growth factor 23 (FGF23) are poorly characterized among dialysis patients.

Objectives: To identify different FGF23 trajectories and determine clinical factors that predict distinct FGF23 trajectories and whether FGF23 trajectories differ in regard to their associations with all-cause mortality among prevalent hemodialysis patients.

Methods: The HEMO study was a randomized multicenter study evaluating the effects of high-dose vs. standard-dose and high-flux vs. low-flux hemodialysis on mortality. We measured intact FGF23 levels in stored serum samples at baseline and annually among 919 HEMO participants and identified FGF23 trajectories using group-based modeling. Logistic regression determined predictors of trajectories. Cox regression models evaluated the association between trajectory and all-cause mortality.

Results: We identified 5 distinct FGF23 trajectory groups during the initial 24 months: low stable, low increasing, elevated increasing, elevated decreasing, and elevated stable. In multivariable models, diabetes, high dose dialysis, no venous catheter, low serum calcium, phosphorus, and interleukin-6, no vitamin D analog use, and greater residual kidney function were associated with the low stable trajectory group compared to the elevated stable group. High flux dialysis, no venous catheter, and low serum phosphorus and 25-hydroxyvitamin D were associated with the elevated decreasing trajectory group compared to the elevated stable group. After full adjustment, the low stable trajectory group was associated with reduced mortality (hazard ratio [HR] 0.61; 95% CI -0.41-0.91) compared to the elevated stable trajectory group.

Conclusions: We identified 5 distinct FGF23 trajectories over 24 months among HEMO study participants including a decreasing trajectory. The low stable FGF23 trajectory was associated with a reduced HR of all-cause mortality.

Keywords: Fibroblast growth factor 23; Hemodialysis; Trajectories.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Fibroblast Growth Factor 23 Trajectories over 24 Months
See this image and copyright information in PMC

References

    1. United States Renal Data System [Internet]. Annual Data Report [Cited 2015 Nov 2015]. Available from: http://www.usrds.org/2015/view/v206.aspx.
    1. Evenepoel P, Rodriguez M, Ketteler M. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? Semin Nephrol. 2014. March;34(2):151–63. - PubMed
    1. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011. November;121(11):4393–408. - PMC - PubMed
    1. Honda H, Michihata T, Shishido K, Takahashi K, Takahashi G, Hosaka N, et al. High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients. PLoS One. 2017. June1;12(6): e0179139. - PMC - PubMed
    1. Chonchol M, Greene T, Zhang Y, Hoofnagle AN, Cheung AK. Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associated with Infectious and Cardiac Deaths in the HEMO Study. J Am Soc Nephrol. 2016. January;27(1):227–37. - PMC - PubMed

Publication types

MeSH terms

Substances